1 / 6

Bones and Kidneys and Bisphosphonates… OH MY!

Bones and Kidneys and Bisphosphonates… OH MY!. Sandra Katalinic. PICO Question.

kert
Télécharger la présentation

Bones and Kidneys and Bisphosphonates… OH MY!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bones and Kidneys and Bisphosphonates… OH MY! Sandra Katalinic

  2. PICO Question • In a 73 year old female with osteoporosis, Paget’s disease, and chronic kidney failure (CrCl ≈ 10ml/min), what is the safe and effective recommended dose of alendronate for the treatment of pain and slowing progression of bony growths secondary to Paget's disease as compared to a patient with normally functioning kidneys (CrCl ≥60ml/min)?

  3. Search Strategy • DiPiro, Up-to-date, CPS • PubMed, Google, First Consult • Merck-Frosst “help-line” • Search Terms: alendronate, Fosamax, Paget’s disease, kidney failure, kidney disease, dialysis, hemodialysis.

  4. Findings • Regular Paget’s Dosing • 40mg PO daily x 6 months  reassess • Dosing in dialysis • Bisphosphonates contraindicated for use in patients with kidney dysfunction (CrCl < 35ml/min) or those on dialysis • Alendronate / bisphosphonates not removed by dialyzing fluid • Vd = 2576L ; 78% protein bound • No well studied recommended dose in this population

  5. However…. • Paget’s Disease of Bone in a Patient on Hemodialysis – Iranian Journal of Kidney Disease (Apr. 2008) • Case study of 77 y/o female w/ Paget's and on hemodialysis (ESRD) • Given 70mg alendronate q week x 6mo • Reassessed and symptom free, AlkPhos normalized (30-120U/L) • Hemo-clinic 35mg twice weekly  reassess in 3 mo • Pain, bony growth / remodeling, AlkPhos

  6. ?

More Related